Donor Login
Contact Us
Breakthrough T1D
About
Investment Strategy
Portfolio
Our Team
News
Donor Login
Get in Touch
News and Press
The T1D Fund Strengthens Expertise With Appointment of Biotech Industry Veteran and Cell Therapy Expert Teresa Foy, Ph.D., to Advance Next Generation of Type 1 Diabetes (“T1D”) Therapies
January 21, 2026
Zag Bio™ Launches with $80 Million Financing to Advance Thymus-targeted Medicines for Autoimmune Diseases
October 28, 2025
The T1D Fund Announces Lucio Iannone, Ph.D., as Managing Director to Accelerate Investments in Curative T1D Therapies
June 16, 2025 |
BOSTON, Mass.
The T1D Fund Announces Daniel McNamara as Head of Strategy & Industry Engagement to Grow the T1D Fund Brand and Drive Greater Interest in T1D Investments
May 13, 2025 |
BOSTON, Mass.
Zucara Therapeutics Announces Second and Final Closing of US$25 Million Series B Financing
May 01, 2025 |
Toronto, Canada
